Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Braz. j. med. biol. res ; 45(12): 1295-1300, Dec. 2012. tab
Article in English | LILACS | ID: lil-659654

ABSTRACT

Ventilator-associated pneumonia (VAP) remains one of the major causes of infection in the intensive care unit (ICU) and is associated with the length of hospital stay, duration of mechanical ventilation, and use of broad-spectrum antibiotics. We compared the frequency of VAP 10 months prior to (pre-intervention group) and 13 months after (post-intervention group) initiation of the use of a heat and moisture exchanger (HME) filter. This is a study with prospective before-and-after design performed in the ICU in a tertiary university hospital. Three hundred and fourteen patients were admitted to the ICU under mechanical ventilation, 168 of whom were included in group HH (heated humidifier) and 146 in group HME. The frequency of VAP per 1000 ventilator-days was similar for both the HH and HME groups (18.7 vs 17.4, respectively; P = 0.97). Duration of mechanical ventilation (11 vs 12 days, respectively; P = 0.48) and length of ICU stay (11 vs 12 days, respectively; P = 0.39) did not differ between the HH and HME groups. The chance of developing VAP was higher in patients with a longer ICU stay and longer duration of mechanical ventilation. This finding was similar when adjusted for the use of HME. The use of HME in intensive care did not reduce the incidence of VAP, the duration of mechanical ventilation, or the length of stay in the ICU in the study population.


Subject(s)
Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Young Adult , Hot Temperature , Pneumonia, Ventilator-Associated/prevention & control , Respiration, Artificial/instrumentation , Critical Illness , Humidity , Intensive Care Units , Length of Stay , Prospective Studies , Pneumonia, Ventilator-Associated/etiology , Risk Factors , Respiration, Artificial/adverse effects
2.
Braz. j. med. biol. res ; 43(8): 794-798, Aug. 2010. ilus
Article in English | LILACS | ID: lil-554958

ABSTRACT

Zygomycosis is an infection caused by opportunistic fungi of the Zygomycetes class, specifically those from the Mucorales and Entomophthorales orders. It is an uncommon disease, mainly restricted to immunocompromised patients. We report a case of a 73-year-old male patient with a history of fever (39°C) lasting for 1 day, accompanied by shivering, trembling, and intense asthenia. The patient was admitted to the intensive care unit with complex partial seizures, and submitted to orotracheal intubation and mechanical ventilation under sedation with midazolam. The electroencephalogram showed evidence of non-convulsive status epilepticus. There is no fast specific laboratory test that permits confirmation of invasive fungal disease. Unless the physician suspects this condition, the disease may progress rapidly while the patient is treated with broad-spectrum antibiotics. Differential diagnosis between fungal and bacterial infection is often difficult. The clinical presentation is sometimes atypical, and etiological investigation is not always successful. In the present case, the histopathological examination of the biopsy obtained from the right temporal lobe indicated the presence of irregular, round, thick-walled fungi forming papillae and elongated structures of irregular diameter, with no septa, indicative of zygomycete (Basidiobolus). Treatment with liposomal amphotericin B and fluconazole was initiated after diagnosis of meningoencephalitis by zygomycete, with a successful outcome.


Subject(s)
Aged , Humans , Male , Entomophthorales/isolation & purification , Meningoencephalitis/microbiology , Shock, Septic/microbiology , Zygomycosis/diagnosis , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Follow-Up Studies , Fluconazole/therapeutic use , Immunocompromised Host , Meningoencephalitis/diagnosis , Meningoencephalitis/drug therapy , Shock, Septic/diagnosis , Shock, Septic/drug therapy , Treatment Outcome , Zygomycosis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL